2019 - Pharmacist Digest

Gender-affirming surgeries tripled in the U.S. between 2016-2019, study finds

STAT

AUGUST 23, 2023

nearly tripled between 2016 and 2019, according to new national estimates from a cohort study in JAMA Network Open. The number of gender-affirming surgeries taking place in the U.S.

More than 31,000 ARRS staff recruited since 2019

The Pharmacist

OCTOBER 18, 2023

More than 31,000 staff – including pharmacists, mental health practitioners and social prescribers – have been recruited to work in general practice under the Additional Roles Reimbursement Scheme (ARRS) since 2019.

Opinion: Independent doctors like me are becoming an endangered species

STAT

FEBRUARY 15, 2024

More than 100,000 doctors have left private practice and become employees of hospitals and other corporate entities since 2019. Today, nearly three in four physicians are employees of larger health care entities or other corporations — a record high.

Hospitals

Alcohol is driving a half-dozen types of cancer in the U.S., study finds

STAT

JULY 11, 2024

Data was from 2019 in order to avoid the influence of the pandemic, when cancer diagnoses declined because of delayed care. The results were published in the American Cancer Society’s journal, CA: A Cancer Journal for Clinicians.

Ambitious federal study failed to curb opioid deaths, NIH announces

STAT

JUNE 16, 2024

In 2019, amid an ever-worsening drug crisis, the federal government launched a research study with an ambitious goal: to lower opioid overdoses in participating communities by 40% using evidence-based interventions like distributing naloxone and providing access to addiction medications.

Opinion: The coronavirus lab leak hypothesis is damaging science

STAT

AUGUST 2, 2024

Where and when the Covid-19 pandemic began — in Wuhan, China in late 2019 — is well known. How it began is a matter of heated controversy. There are two competing hypotheses, one of which is hindering the process of scientific discovery and could hold back the development of vaccines and other antiviral agents in the U.S.

Vaccines

STAT+: AI versus AI: The emerging arms race over health insurance denials

STAT

DECEMBER 12, 2024

The software engineer’s disillusionment began in 2019, when her insurer, UnitedHealthcare, balked at covering physical therapy after she was hit by a car and could not walk. Like many Americans, Holden Karau said she was fed up with health insurance.

There’s a knowledge gap about miscarriages in the U.S., and researchers hope to close it

STAT

AUGUST 21, 2024

Megan Hanson was eight weeks pregnant in 2019 when she experienced a miscarriage — her sixth consecutive loss in as many years. It felt particularly cruel after a second IVF transfer.

Denied by AI: How Medicare Advantage plans use algorithms to cut off care for seniors in need

STAT

MARCH 13, 2023

Meanwhile, medical notes in June 2019 showed Walter’s pain was maxing out the scales and that she could not dress herself, go to the bathroom, or even push a walker without help. Read the rest…

Nursing Homes

Routine vaccinations drop among U.S. kindergartners for the third year in a row

STAT

JANUARY 12, 2023

Vaccinations among children remain high, but the trend — with coverage dropping from about 95% in the 2019-2020 school year to 94% in 2020-2021 to 93% in 2021-2022, according to the data released Thursday — has health officials concerned. The percentage of U.S.

Vaccines

APAC leads in asthma clinical trials between 2019-2023: GlobalData

Express Pharma

MAY 6, 2024

According to GlobalData’s Clinical Trials Database, during 2019-23, 51.8 The post APAC leads in asthma clinical trials between 2019-2023: GlobalData appeared first on Express Pharma. per cent of asthma trials were initiated in the APAC region.

Life expectancy for men in U.S. falls to 73 years — six years less than for women, per study

STAT

NOVEMBER 13, 2023

years in 2019 to 77 in 2020 and 76.1 At least partially as a consequence of over 1 million Covid-19 deaths, life expectancy in the U.S. has declined significantly over the past few years, falling from 78.8 in 2022 — undoing over two decades of progress. and Italy all enjoy a life expectancy of 80 years or more.

Juul’s internal playbook opens a rare window into influence in Washington

STAT

FEBRUARY 15, 2024

WASHINGTON — A new trove of internal emails and other documents from the e-cigarette maker Juul reveals the company’s extensive behind-the-scenes efforts to promote its interests in Washington — a rare insight into the otherwise opaque methods corporations use to influence the government.

Documentation

STAT+: Addiction treatment center founder indicted in sprawling fraud scheme

STAT

MAY 24, 2023

Over the last few years, Daniel Cleggett Jr. appeared to be living a charmed life.

Second-generation mosquito nets prevented 13 million malaria cases in large pilot programs

STAT

APRIL 17, 2024

Results shared this week by the New Nets Project, an initiative funded by Unitaid and the Global Fund, highlighted a pair of second-generation bed nets tested in endemic areas between 2019 and 2022.

STAT+: Former medical device CEO who sold dummy, plastic parts convicted of fraud

STAT

MARCH 7, 2024

Laura Perryman led Stimwave, which sold nerve stimulation devices to combat pain, from 2010 to 2019. STAT published new details about the Stimwave story in May, after former employees described how Perryman broke into Stimwave’s Florida headquarters to steal back devices after her termination in 2019.

Nurses and health care support workers at higher risk of suicide, study finds

STAT

SEPTEMBER 26, 2023

million employed people (both within the health care field and outside) observed from 2008 to 2019. While other research has examined the incidence of mental health issues and suicide risk among physicians, the same isn’t necessarily true of other health care professions.

STAT+: Pfizer pulls sickle cell treatment Oxbryta off global markets

STAT

SEPTEMBER 25, 2024

The decision is a stunning blow for a drug that was approved in 2019 , heralded as a new way to treat the inherited blood disorder. Pfizer said Wednesday that it was removing Oxbryta, a pill for the treatment of sickle cell disease, from all markets globally due to high risks of severe safety events, including deaths.

STAT+: Contributors to psychiatry’s bible, the DSM-5, got $14 million from industry

STAT

JANUARY 10, 2024

This latest revision, known as the DSM-5-TR, was prepared between 2016 and 2019, and published in 2022. -based physicians who helped assemble a recent revision of the Diagnostic and Statistical Manual of Mental Disorders, which is often referred to as the bible of psychiatry.

Pharmaceutical Companies

Pharmaceutical Companies Pharmaceutical Companies

New analysis reveals postpartum sterilization rates are higher among U.S. women with sickle cell

STAT

OCTOBER 1, 2024

Performed by researchers at Johns Hopkins University, the study found that between 2012 and 2019, 8.8% . Now, a data analysis commissioned by STAT shows that the rate of postpartum sterilization is significantly higher in Americans with sickle cell disease than in those without. of births to unaffected mothers did.

STAT+: A rare disease program, portrayed as both lifeline and pharma handout, is set to expire

STAT

SEPTEMBER 12, 2024

After his son Michael was diagnosed with a devastating, ultra-rare disease in 2019, Terry Pirovolakis dedicated himself to eradicating it. Pirovolakis, a Canadian IT director, recruited academics and raised $3 million to design a gene therapy.

Lead aprons not necessary for patients during X-rays, says largest U.S. dental group

STAT

FEBRUARY 2, 2024

In 2019, the American Associations of Physicists in Medicine concluded that the use of patient lead aprons should be discontinued as they were both unnecessary for safety and had the potential to jeopardize the quality of images. Other medical organizations have been making similar points for some time.

Gates Foundation to fund trial of long-awaited new tuberculosis vaccine candidate

STAT

JUNE 28, 2023

The 26,000-person, Phase 3 study, set to begin next year, will test a vaccine known as M72/AS01 that showed promising results from a smaller trial in 2019. The Gates Foundation unveiled plans Wednesday to fund a long-awaited trial for what, if proven effective, would be the first new tuberculosis vaccine in over a century.

Vaccines

Youth vaping continues its tumble from a Juul-fueled high

STAT

SEPTEMBER 5, 2024

Around 6% of middle and high school students used vapes in 2024, down from 8% last year, and a record high of 20% in 2019, according to a survey released Thursday by the FDA and the CDC. The number of U.S. The vape brand Juul fueled this surge, but has since receded in popularity after FDA actions and legal challenges.

STAT+: After early wins, CRISPR gene editing is about to get a lot harder

STAT

SEPTEMBER 21, 2022

The short history of CRISPR gene editing in humans has, with rare exception, been a history of triumphant progress: A patient apparently cured of sickle cell in 2019, six patients with toxic DNA knocked out of their liver last year, another six patients with a different strand of toxic liver DNA knocked out last week.

STAT+: As Medicare spending on remote patient monitoring jumps, HHS watchdog warns of fraud, misuse

STAT

SEPTEMBER 23, 2024

In just four years from the beginning of 2019 through 2022, according to the report, the number of Medicare patients receiving RPM increased tenfold, from 55,000 to 570,000. Remote patient monitoring has exploded since the pandemic. Medicare Advantage use increased 14 times over. Medicare Advantage use increased 14 times over.

Is the future of AI in health care just a lot of hype?

STAT

OCTOBER 10, 2024

Narayan, a professor of computer science at Princeton University, went viral in 2019 for a talk he gave at MIT on how to recognize overblown declarations about AI’s capabilities. Now he’s teamed up with his Ph.D. student Kapoor to publish the book “ AI Snake Oil ,” which came out Sep.

Drug Development

Drug Development Hospitals

STAT+: Jiankui He, creator of CRISPR-edited children, relocates to a Chinese medical tourism hub

STAT

JULY 24, 2024

In January 2019, provincial health authorities found that He’s human CRISPR experiments violated national regulations against gene-editing for reproductive purposes.

STAT+: SEC charges former CEO of pain relief device company with $41 million fraud

STAT

DECEMBER 20, 2023

Laura Perryman led Stimwave, which sold nerve stimulation devices to combat pain, from 2010 to 2019, when the fraud came to light. The Securities and Exchange Commission on Tuesday charged the former CEO of Stimwave, a company that sold devices containing dummy pieces of plastic, with defrauding investors out of $41 million.

Air quality improvements belie rising racial and ethnic disparities in pollutant-related deaths, study finds

STAT

MARCH 5, 2024

Researchers found an overall drop from 2010 and 2019 in death and disease linked to nitrogen dioxide (NO2), an air pollutant produced from fossil fuel burning, and fine particulate matter (PM2.5) Deaths attributable to PM2.5

STAT+: Gilead’s chief medical officer to leave as R&D efforts stall

STAT

JULY 17, 2024

Merdad Parsey, who joined Gilead in 2019, will stay in his post until the first quarter of next year as the company looks for a successor, Gilead said in a press release Wednesday. Gilead has faced multiple setbacks in its attempt to move away from its stronghold in virology and into other areas like cancer.

Scientists, going on a bear hunt, find a potential way to treat deadly blood clots

STAT

APRIL 13, 2023

But one week in February 2019, her work brought her to a snowy Swedish forest, where she stood shuddering in a winter coat, looking on as veterinarians and rangers walked into a bear den to drug a hibernating bear and retrieve its blood.

Hospitals

STAT wants to know your pick for a great summer read or listen

STAT

MAY 30, 2023

To get a little inspiration, check out our past lists from 2022 , 2021 , and 2019. We invite our readers to fill out the form below, and you may see your pick in our upcoming annual roundup.

Cannabis industry scales back its lobbying in Washington

STAT

AUGUST 1, 2023

Curaleaf, one the largest cannabis companies in the world, spent nearly 40% less on lobbying in the first half of 2023 than it did at its peak in 2019. Together, their spending on advocacy has dipped by more than 50% since 2019, back when federal weed lobbying was at its height. Read the rest…

‘We’re failing to make progress’: Studies show ongoing toll of premature Black deaths

STAT

MAY 16, 2023

The analysis showed improvement was made in narrowing long-standing health gaps between Black and white Americans between 1999 and 2011, but progress stalled through 2019. In the last two decades, Black Americans have suffered 1.63

STAT+: In a big reversal, Walmart to shut down medical clinics and online care

STAT

APRIL 30, 2024

Walmart had grand ambitions , back in 2019, to grow a network of cheaper primary care clinics attached to its ubiquitous stores. Those ambitions are now dead. The retail giant said Tuesday it is shuttering its 51 medical clinics across five states, as well as its virtual care offering.

Opinion: Providers shouldn’t be afraid of buprenorphine for opioid use disorder making it into the hands of someone without a prescription

STAT

JANUARY 5, 2024

One analysis using emergency department data found that the percentage of encounters with patients with opioid use disorder that resulted in a buprenorphine prescription increased from 2% in 2019 to 8% in 2023. While this increase is encouraging, it is not the scale-up in treatment many hoped for.This raises a simple question: Why?

STAT+: Brain biopsies on ‘vulnerable’ patients at Mount Sinai set off alarm bells at FDA, documents show

STAT

MAY 1, 2024

” What Bauman couldn’t have known was that roughly one year earlier, the Mount Sinai brain biopsies had set off alarm bells at the Food and Drug Administration, whose review had been triggered when a device manufacturer wrote to the agency in April 2019.

Documentation

Documentation Nursing Homes

STAT+: U.S. drug shortages have reached a decade high and are lasting longer, too

STAT

JUNE 4, 2024

This was also the highest rate of product discontinuations since 2019. These low prices also translated into more product discontinuations, which rose by 40% from 2022 to 2023, and from 100 drugs to 140 during that time. Continue to STAT+ to read the full story…

STAT+: Oncologists more likely to provide low-value care after receiving pharma money, study finds

STAT

OCTOBER 25, 2023

The researchers examined Medicare beneficiaries who were diagnosed with cancer and received treatment from 2014 through 2019. Overall, the proportion of patients who were prescribed so-called low-value drugs was higher when their oncologist accepted industry payments, according to the study, published in the BMJ.

Chemotherapy

Chemotherapy Pharmaceutical Companies Pharmaceutical Companies

Kellogg’s is going to war over Mexico’s nutrition label rules. A similar fight is coming to the U.S.

STAT

AUGUST 21, 2023

A 2019 policy requires companies that make unhealthy foods to include warning labels on the front of any boxes they sell in Mexico to educate consumers about things like excess sugar and fat. MEXICO CITY — Kellogg’s is waging a war here over Tigre Toño and Sam el Tucán.

Labelling

Labelling Packaging

STAT+: Just how much money do drugmakers gain from patent extensions?

STAT

SEPTEMBER 26, 2023

The organization looked at four blockbuster drugs — Humira, Avastin, Rituxan, and Lantus — that had biosimilars launched between 2019 and 2023. years of unchallenged market presence.

Drug Pricing

Drug Pricing Biosimilars Drug Development

Opinion: Sonya Massey’s death: How to prevent more killings of defenseless Black women

STAT

JULY 26, 2024

Between 2019 and 2021, approximately 180 calls for help resulted in law enforcement shooting and killing the very people in need. After the shooting, Grayson labeled her as “crazy” and not deserving of first aid.

Labelling

STAT+: Chick-fil-A drops a ‘No Antibiotic Ever’ pledge on chicken over supply issues

STAT

MARCH 25, 2024

a decade after the chain announced it would implement a “No Antibiotics Ever” policy by 2019. The change will occur this spring at the slightly more than 3,000 Chick-fil-A locations around the U.S, The move comes amid changes by key suppliers.

Labelling

Gender-affirming surgeries tripled in the U.S. between 2016-2019, study finds

More than 31,000 ARRS staff recruited since 2019

Trending Sources

Opinion: Independent doctors like me are becoming an endangered species

Alcohol is driving a half-dozen types of cancer in the U.S., study finds

Ambitious federal study failed to curb opioid deaths, NIH announces

Opinion: The coronavirus lab leak hypothesis is damaging science

STAT+: AI versus AI: The emerging arms race over health insurance denials

There’s a knowledge gap about miscarriages in the U.S., and researchers hope to close it

Denied by AI: How Medicare Advantage plans use algorithms to cut off care for seniors in need

Routine vaccinations drop among U.S. kindergartners for the third year in a row

APAC leads in asthma clinical trials between 2019-2023: GlobalData

Life expectancy for men in U.S. falls to 73 years — six years less than for women, per study

Juul’s internal playbook opens a rare window into influence in Washington

STAT+: Addiction treatment center founder indicted in sprawling fraud scheme

Second-generation mosquito nets prevented 13 million malaria cases in large pilot programs

STAT+: Former medical device CEO who sold dummy, plastic parts convicted of fraud

Nurses and health care support workers at higher risk of suicide, study finds

STAT+: Pfizer pulls sickle cell treatment Oxbryta off global markets

STAT+: Contributors to psychiatry’s bible, the DSM-5, got $14 million from industry

New analysis reveals postpartum sterilization rates are higher among U.S. women with sickle cell

STAT+: A rare disease program, portrayed as both lifeline and pharma handout, is set to expire

Lead aprons not necessary for patients during X-rays, says largest U.S. dental group

Gates Foundation to fund trial of long-awaited new tuberculosis vaccine candidate

Youth vaping continues its tumble from a Juul-fueled high

STAT+: After early wins, CRISPR gene editing is about to get a lot harder

STAT+: As Medicare spending on remote patient monitoring jumps, HHS watchdog warns of fraud, misuse

Is the future of AI in health care just a lot of hype?

STAT+: Jiankui He, creator of CRISPR-edited children, relocates to a Chinese medical tourism hub

STAT+: SEC charges former CEO of pain relief device company with $41 million fraud

Air quality improvements belie rising racial and ethnic disparities in pollutant-related deaths, study finds

STAT+: Gilead’s chief medical officer to leave as R&D efforts stall

Scientists, going on a bear hunt, find a potential way to treat deadly blood clots

STAT wants to know your pick for a great summer read or listen

Cannabis industry scales back its lobbying in Washington

‘We’re failing to make progress’: Studies show ongoing toll of premature Black deaths

STAT+: In a big reversal, Walmart to shut down medical clinics and online care

Opinion: Providers shouldn’t be afraid of buprenorphine for opioid use disorder making it into the hands of someone without a prescription

STAT+: Brain biopsies on ‘vulnerable’ patients at Mount Sinai set off alarm bells at FDA, documents show

STAT+: U.S. drug shortages have reached a decade high and are lasting longer, too

STAT+: Oncologists more likely to provide low-value care after receiving pharma money, study finds

Kellogg’s is going to war over Mexico’s nutrition label rules. A similar fight is coming to the U.S.

STAT+: Just how much money do drugmakers gain from patent extensions?

Opinion: Sonya Massey’s death: How to prevent more killings of defenseless Black women

STAT+: Chick-fil-A drops a ‘No Antibiotic Ever’ pledge on chicken over supply issues

Stay Connected